Congratulations to Cognition Therapeutics, Inc. on their IPO! Golden Seeds first invested in 2010 and has marveled at its progress throughout these years. We are proud beyond measure of this women-led company. Kudos to CEO Lisa Ricciardi, Founder/Chief Science Officer Dr. Susan Catalano and the Cognition team.
Golden Seeds has reached a historic milestone: $150 million in total investments in its effort to transform angel investing and achieve gender parity in entrepreneurship. Since 2005, we have financed more than 200 companies, which have gone on to raise more than $1.5 billion of total capital, demonstrating the incredible momentum of women entrepreneurs and the commitment of those investors who want to reshape the investment landscape